Pathogenic fungi have emerged as significant causes of infectious morbidity and death in
patients with acquired immunodeficiency conditions such as HIV/AIDS and following receipt …

Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Aspergillus species are the most frequent cause of fungal infections of the lungs with a
broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) …

Potential airborne human pathogens (PAHPs) may be a relevant component of the air
microbiome in built environments. Despite that PAHPs can cause infections, particularly in …

Abstract Purpose of Review For this review, we use a One Health approach to examine two
globally emerging public health threats related to antifungal drug resistance: triazole …

Molds are ubiquitous in the environment, and immunocompromised patients are at
substantial risk of morbidity and mortality due to their underlying disease and the resistance …

Nosocomial clusters of fungal infections, whilst uncommon, cannot be predicted and are
associated with significant morbidity and mortality. Here, we review reports of nosocomial …

Infections due to the Aspergillus species constitute an important challenge for human health.
Invasive aspergillosis represents a life-threatening disease, mostly in patients with immune …

Fungal infections remain a significant concern for human health. The emergence of
microbial resistance, the improper use of antimicrobial drugs, and the need for fewer toxic …

Fungal infections are a serious global concern because of their ability to spread and
colonize host tissues in immunocompromised individuals. Such infections have been …